Indo Riv Clinical Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-07-2024
- Paid Up Capital ₹ 1.40 M
as on 16-07-2024
- Company Age 34 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.90 M
as on 16-07-2024
- Revenue 44.06%
(FY 2023)
- Profit 447.42%
(FY 2023)
- Ebitda 102.02%
(FY 2023)
- Net Worth 51.97%
(FY 2023)
- Total Assets 74.33%
(FY 2023)
About Indo Riv Clinical
The Corporate was formerly known as Indo Riv Farm And Marine Products Pvt Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.40 M.
The company currently has active open charges totaling ₹1.90 M.
Anant Agarwal and Ravi Agarwal serve as directors at the Company.
- CIN/LLPIN
U05004WB1990PTC050110
- Company No.
050110
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Nov 1990
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Indo Riv Clinical Private Limited offer?
Indo Riv Clinical Private Limited offers a wide range of products and services, including Material Testing Labs & Services, Testing Services, Pharma & Bioanalytical Services, Pharmaceutical Services, Diagnostic Imaging & Pathology Labs, Medical Test Services, Fitness Clubs and Beauty Parlours, Health Club Services.
Who are the key members and board of directors at Indo Riv Clinical?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anant Agarwal  | Director | 31-Mar-2015 | Current |
| Ravi Agarwal | Director | 05-Nov-1990 | Current |
Financial Performance of Indo Riv Clinical.
Indo Riv Clinical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 44.06% increase. The company also saw a substantial improvement in profitability, with a 447.42% increase in profit. The company's net worth Soared by an impressive increase of 51.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indo Riv Clinical?
In 2023, Indo Riv Clinical had a promoter holding of 95.00% and a public holding of 5.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 Sep 2022 | ₹1.90 M | Open |
How Many Employees Work at Indo Riv Clinical?
Indo Riv Clinical has a workforce of 44 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indo Riv Clinical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indo Riv Clinical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
